The downrampers seem confused about the entitlement offer, about how Directors have participated, and how it effects the balance sheet upon completion.
MMR had three outstanding liabilities as at 30/6/24:-
Money owed to BPH
Money owed to Directors
Money owed to Advent
With the proceeds of the entitlement offer, it is proposed that the debt to BPH will be repaid in cash.
With the money owed to Directors, each has elected to offset the amount owing with new shares.
With the money owed to Advent, Advent has elected to offset the amount owing with new shares.
Therefore, post completion of the offer, it is envisaged that the company will have NO liabilities.
The company will have a forecast balance of over $3M in cash, a $4M asset by way of a loan from MMR to Advent, NAV of circa $7M. That translates to an EV of $0 for it's other assets which includes it's 38% stake in Advent.
JMO. DYOR. GLTAH.
- Forums
- ASX - By Stock
- MMR
- Ann: Timetable Update & ASX Reinstatement
MMR
mec resources limited
Add to My Watchlist
0.00%
!
0.5¢

Ann: Timetable Update & ASX Reinstatement, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.248M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $7.05K | 1.41M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1460819 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 7589369 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1460819 | 0.004 |
12 | 9680135 | 0.003 |
5 | 4850000 | 0.002 |
11 | 32105000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 7589369 | 10 |
0.006 | 7586657 | 4 |
0.007 | 8089274 | 3 |
0.008 | 4000000 | 1 |
0.015 | 310000 | 1 |
Last trade - 15.47pm 25/06/2025 (20 minute delay) ? |
Featured News
MMR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online